ATE414762T1 - Herstellung kultivierter menschlicher mastzellen und basophilen zur hochdurchsatz-entdeckung kleiner arzneistoffmoleküle - Google Patents

Herstellung kultivierter menschlicher mastzellen und basophilen zur hochdurchsatz-entdeckung kleiner arzneistoffmoleküle

Info

Publication number
ATE414762T1
ATE414762T1 AT02763580T AT02763580T ATE414762T1 AT E414762 T1 ATE414762 T1 AT E414762T1 AT 02763580 T AT02763580 T AT 02763580T AT 02763580 T AT02763580 T AT 02763580T AT E414762 T1 ATE414762 T1 AT E414762T1
Authority
AT
Austria
Prior art keywords
cells
mast cells
screening
methods
basophils
Prior art date
Application number
AT02763580T
Other languages
English (en)
Inventor
Alexander Rossi
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE414762T1 publication Critical patent/ATE414762T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0642—Granulocytes, e.g. basopils, eosinophils, neutrophils, mast cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02763580T 2001-08-31 2002-08-29 Herstellung kultivierter menschlicher mastzellen und basophilen zur hochdurchsatz-entdeckung kleiner arzneistoffmoleküle ATE414762T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31672301P 2001-08-31 2001-08-31
US10/053,355 US7070996B2 (en) 2001-08-31 2001-11-08 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery

Publications (1)

Publication Number Publication Date
ATE414762T1 true ATE414762T1 (de) 2008-12-15

Family

ID=26731760

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02763580T ATE414762T1 (de) 2001-08-31 2002-08-29 Herstellung kultivierter menschlicher mastzellen und basophilen zur hochdurchsatz-entdeckung kleiner arzneistoffmoleküle

Country Status (8)

Country Link
US (2) US7070996B2 (de)
EP (1) EP1427812B1 (de)
JP (1) JP4388372B2 (de)
AT (1) ATE414762T1 (de)
AU (1) AU2002327583A1 (de)
DE (1) DE60229960D1 (de)
DK (1) DK1427812T3 (de)
WO (1) WO2003020896A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029697B2 (en) 2001-02-14 2006-04-18 Northwestern University Controlled surface-associated delivery of genes and oligonucleotides
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
WO2004015389A2 (en) * 2002-08-09 2004-02-19 Rigel Pharmaceuticals, Inc. Methods of identifying compouds that modulate igg mediated mast cell activation
KR101201603B1 (ko) 2003-07-30 2012-11-14 리겔 파마슈티칼스, 인크. 자가면역 질환의 치료 또는 예방에 사용하기 위한2,4-피리미딘디아민 화합물
US20050265980A1 (en) * 2004-05-14 2005-12-01 Becton, Dickinson And Company Cell culture environments for the serum-free expansion of mesenchymal stem cells
WO2006004865A1 (en) * 2004-06-29 2006-01-12 Rigel Pharmaceuticals, Inc. 2-substituted quinoline compounds and their uses as inhibitors of the ige receptor signaling cascade
CN1993460A (zh) * 2004-07-12 2007-07-04 索林集团意大利有限公司 用于培养人细胞的装置和方法
PL1984357T3 (pl) 2006-02-17 2014-03-31 Rigel Pharmaceuticals Inc Związki 2,4-pirymidynodiaminy do leczenia lub zapobiegania chorób autoimmunologicznych
US20100015615A1 (en) * 2008-04-30 2010-01-21 Sloan-Kettering Institute For Cancer Research Identification and Isolation of Adult Stem Cells and Related Methods of Use
US9096829B2 (en) 2009-03-12 2015-08-04 University Of South Florida Human mast cell line and uses thereof
WO2011030915A1 (en) 2009-09-08 2011-03-17 Kyoto University Method for producing mast cells from pluripotent stem cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2052035A (en) * 1932-03-21 1936-08-25 Thomas R Potter Combination game board and accessories
US4559310A (en) * 1983-05-20 1985-12-17 Dana Farber Cancer Institute Assay methods and systems utilizing mast cell clones
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US6190655B1 (en) 1993-12-03 2001-02-20 Immunex Corporation Methods of using Flt-3 ligand for exogenous gene transfer
FR2728584A1 (fr) * 1994-12-22 1996-06-28 Centre Nat Rech Scient Procede de transfert de gene dans des cellules activees a partir d'un etat de repos
US6261841B1 (en) 1999-06-25 2001-07-17 The Board Of Trustees Of Northwestern University Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells

Also Published As

Publication number Publication date
EP1427812A4 (de) 2005-04-27
AU2002327583A1 (en) 2003-03-18
EP1427812B1 (de) 2008-11-19
DK1427812T3 (da) 2009-03-16
DE60229960D1 (de) 2009-01-02
JP4388372B2 (ja) 2009-12-24
US20070015280A1 (en) 2007-01-18
WO2003020896A2 (en) 2003-03-13
US20030077824A1 (en) 2003-04-24
EP1427812A2 (de) 2004-06-16
WO2003020896A9 (en) 2003-12-18
WO2003020896A3 (en) 2003-10-30
JP2005501552A (ja) 2005-01-20
US7070996B2 (en) 2006-07-04

Similar Documents

Publication Publication Date Title
ATE414762T1 (de) Herstellung kultivierter menschlicher mastzellen und basophilen zur hochdurchsatz-entdeckung kleiner arzneistoffmoleküle
YU83101A (sh) Postupci i materijali za sinteze organskih proizvoda
NZ569543A (en) Means and methods for influencing the stability of antibody producing cells
GB0312481D0 (en) Antibodies
NO20051030L (no) Funksjonelle kardiomyocytter fra humane embryonale stamceller
ATE271606T1 (de) Die aktivierung von rezeptoren durch gas6
ATE407138T1 (de) Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
IL196893A (en) Cell or cell line of vertebrate-containing amino acids trna synthase
ES2191575T1 (es) Un metodo de escrutar sustancias para detectar translocacion intracelular.
ATE278024T1 (de) Methode zur herstellung von rekombinanten zellen
IL151746A0 (en) Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
ATE287945T1 (de) Herstellung und verwendung von dendritischen zellen
HK1047032A1 (zh) 處理解開的蛋白質表現方法的方法及產品
EP3467112A3 (de) Verfahren zur transfektion von nukleinsäure in lebende zellen
DE3855634T2 (de) Innerhalb des alpha-Locus gelegenes T-Zell-Rezeptor-Gen und DNA-Konstruktionen
DE602006014534D1 (de) Herstellung und verwendung von basalmembranpartikeln
WO2004092413A3 (en) High throughput functional genomic screening methods for osteoarthritis
WO2003006947A3 (en) Cell-screening assay and composition
WO2005054447A3 (en) Müller stem cells
WO2003063783A3 (en) Multiple virus replicon culture systems
WO2003044484A3 (en) High-density cell microarrays for parallel functional determinations
FR2815640B1 (fr) Procede de production de proteines par electropulsation de levures
ATE411381T1 (de) Hochdurchsatzsystem zur herstellung rekombinanter viren mittels stellenspezifischer rekombination
Gasser et al. Supra-molecular organization of the pyoverdine bio-synthetic pathway in Pseudomonas aeruginosa
Potvin-Trottier Quantifying and Engineering Protein Dynamics in Bacteria

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1427812

Country of ref document: EP